Phage Therapy Is Effective against Infection by Mycobacterium ulcerans in a Murine Footpad Model

Cellular Immunity Confers Transient Protection in Experimental Buruli Ulcer following BCG or Mycolactone-Negative Mycobacterium ulcerans Vaccination

(2012) Alexandra G. Fraga et al.   PLoS One

Local and Regional Re-Establishment of Cellular Immunity during Curative Antibiotherapy of Murine Mycobacterium ulcerans Infection

(2012) Teresa G. Martins et al.   PLoS One

Experimental Phage Therapy in TreatingKlebsiella pneumoniae-Mediated Liver Abscesses and Bacteremia in Mice

(2011) Chih-Hsin Hung et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models

(2011) Birendra R. Tiwari et al.   JOURNAL OF MICROBIOLOGY

Secondary Buruli Ulcer Skin Lesions Emerging Several Months after Completion of Chemotherapy: Paradoxical Reaction or Evidence for Immune Protection?

(2011) Marie-Thérèse Ruf et al.   PLoS Neglected Tropical Diseases

Severe Multifocal Form of Buruli Ulcer after Streptomycin and Rifampin Treatment: Comments on Possible Dissemination Mechanisms

(2010) Ghislain Emmanuel Sopoh et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Clinical Efficacy of Combination of Rifampin and Streptomycin for Treatment of Mycobacterium ulcerans Disease

(2010) F. S. Sarfo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Buruli Ulcer: Advances in Understanding Mycobacterium ulcerans Infection

(2010) Douglas S. Walsh et al.   DERMATOLOGIC CLINICS

MycobacteriumulceransTriggers T-Cell Immunity followed by Local and Regional but Not Systemic Immunosuppression

(2010) Alexandra G. Fraga et al.   INFECTION AND IMMUNITY

Bacteriophage endolysins: A novel anti-infective to control Gram-positive pathogens

(2010) Vincent A. Fischetti   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial

(2010) Willemien A Nienhuis et al.   LANCET

In vivo efficiency evaluation of a phage cocktail in controlling severe colibacillosis in confined conditions and experimental poultry houses

(2010) Ana Oliveira et al.   VETERINARY MICROBIOLOGY

All-Oral Antibiotic Treatment for Buruli Ulcer: A Report of Four Patients

(2010) Claire L. Gordon et al.   PLoS Neglected Tropical Diseases

Response to Treatment in a Prospective Cohort of Patients with Large Ulcerated Lesions Suspected to Be Buruli Ulcer (Mycobacterium ulcerans Disease)

(2010) Kapay Kibadi et al.   PLoS Neglected Tropical Diseases

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistantPseudomonas aeruginosa; a preliminary report of efficacy

(2009) A. Wright et al.   CLINICAL OTOLARYNGOLOGY

Buruli ulcer

(2009) Françoise Portaels et al.   CLINICS IN DERMATOLOGY

Characterization of a T7-Like Lytic Bacteriophage of Klebsiella pneumoniae B5055: A Potential Therapeutic Agent

(2009) Vivek Verma et al.   CURRENT MICROBIOLOGY

IFN- -Dependent Activation of Macrophages during Experimental Infections by Mycobacterium ulcerans Is Impaired by the Toxin Mycolactone

(2009) E. Torrado et al.   JOURNAL OF IMMUNOLOGY

Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer

(2009) Manuel T Silva et al.   LANCET INFECTIOUS DISEASES

First Cultivation and Characterization of Mycobacterium ulcerans from the Environment

(2008) Françoise Portaels et al.   PLoS Neglected Tropical Diseases